The nurse is assisting the HCP with a bone marrow biopsy. Which intervention postprocedure has priority?
- A. Apply pressure to site for five (5) to 10 minutes.
- B. Medicate for pain with morphine slow IVP.
- C. Maintain head of bed in high Fowler’s position.
- D. Apply oxygen via nasal cannula at five (5) L/min.
Correct Answer: A
Rationale: Applying pressure for 5–10 minutes (A) prevents bleeding post-biopsy, a priority. Pain meds (B), HOB (C), and oxygen (D) are secondary or unrelated.
You may also like to solve these questions
The client diagnosed with sickle cell anemia is experiencing a vaso-occlusive sickle cell crisis secondary to an infection. Which medical treatment should the nurse anticipate the HCP ordering for the client?
- A. Administer meperidine (Demerol) intravenously.
- B. Admit the client to a private room and keep in reverse isolation.
- C. Infuse D5W 0.33% NS at 150 mL/hr via pump.
- D. Insert a 22-French Foley catheter with a urimeter.
Correct Answer: C
Rationale: Hydration with IV fluids (C) prevents sickling in vaso-occlusive crisis. Meperidine (A) is avoided (risks seizures), isolation (B) is excessive, and Foley (D) is unnecessary.
The client undergoing intensive chemotherapy for Hodgkin’s lymphoma (HL) is hospitalized with fever and depressed immune system functioning. The nurse is administering filgrastim subcutaneously daily. Which laboratory value should the nurse monitor to determine the medication’s effectiveness?
- A. Hemoglobin
- B. Platelet count
- C. Absolute neutrophil count (ANC)
- D. Reed-Sternberg cells
Correct Answer: C
Rationale: A. Epoetin alfa, not filgrastim, is used to treat anemia that is associated with cancer, and its effectiveness would be reflected in the Hgb values. B. Oprelvekin (Neumega), not filgrastim, enhances the synthesis of platelets. C. The nurse should monitor the ANC. Filgrastim (Neupogen) is usually discontinued when the client’s absolute neutrophil count (ANC) is above 1000 cells/mm3. Filgrastim, a granulocyte colony-stimulating factor (G-CSF) analog, is used to stimulate the proliferation and differentiation of granulocytes and treat neutropenia. D. Reed-Sternberg cells are found in lymph node biopsy cells and are indicative of Hodgkin’s lymphoma; they are not monitored to determine the effectiveness of filgrastim, which is used to treat neutropenia.
Which client is at highest risk for developing a lymphoma?
- A. The client diagnosed with chronic lung disease who is taking a steroid.
- B. The client diagnosed with breast cancer who has extensive lymph involvement.
- C. The client who received a kidney transplant several years ago.
- D. The client who has had ureteral stent placements for a neurogenic bladder.
Correct Answer: C
Rationale: Immunosuppression post-transplant (C) increases lymphoma risk (e.g., PTLD). Steroids (A) are lower risk, breast cancer (B) involves metastasis, and stents (D) are unrelated.
The nurse and the licensed practical nurse (LPN) are caring for clients on an oncology floor. Which client should not be assigned to the LPN?
- A. The client newly diagnosed with chronic lymphocytic leukemia.
- B. The client who is four (4) hours postprocedure bone marrow biopsy.
- C. The client who received two (2) units of (PRBCs) on the previous shift.
- D. The client who is receiving multiple intravenous piggyback medications.
Correct Answer: D
Rationale: IV piggyback medications (D) require complex assessment (e.g., chemotherapy), beyond LPN scope. New diagnosis (A), post-biopsy (B), and post-transfusion (C) are stable for LPN care.
The nurse is transcribing the HCP’s order for an iron supplement on the MAR. At which time should the nurse schedule the daily dose?
- A. 900
- B. 1000
- C. 1200
- D. 1630
Correct Answer: A
Rationale: Iron supplements are best taken in the morning (0900, A) with food to reduce GI upset and enhance absorption. Later times (B, C, D) are less optimal.
Nokea